Blue Crest Capital Management LTD T2 Biosystems, Inc. Transaction History

Blue Crest Capital Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.97 - $9.58 $88,618 - $142,205	-14,844 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$4.21 - $7.0 $37,772 - $62,804	-8,972 Reduced 37.67%	14,844 $96,000
Q4 2017 Feb 14, 2018	BUY	$3.73 - $4.6 $88,833 - $109,553	23,816	23,816 $98,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.